Navigation Links
DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase

New York, NY (PRWEB) March 28, 2013

The medication safety advocates at are announcing updated information on the site for patients taking the blood thinner Pradaxa. Researchers presented the American College of Cardiology with a new study this month warning of Pradaxa bleeding risks***, as the number of injury claims continues to grow****.

DrugRisks was designed to reduce the danger of side effects from popular prescription drugs by providing patients with the latest warnings, recalls, studies and legal news. Visitors can determine if others are experiencing similar side effects and decide whether they need legal advice.

Information on the resource site shows health experts have disagreed about whether those taking Pradaxa to prevent strokes in atrial fibrillation face higher risks for internal bleeding. The FDA has updated its information to state the drug is as safe as warfarin*.

However, the Institute for Safe Medication Practices recently ranked blood thinners like Pradaxa among the most dangerous drugs available. They also cautioned that patients with bleeding from Pradaxa were nearly 5 times as likely to die than those with bleeding from warfarin**.

Now, DrugRisks has added information showing researchers from the University of Illinois at Chicago presented a study to the American College of Cardiology this month warning that the data used by the FDA may be flawed, and the risk for bleeding from Pradaxa may be higher than previously thought***.

Due to the number of patients who have filed a Pradaxa lawsuit over allegations of internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

DrugRisks has also reviewed the latest information from the federal judicial panel on multidistrict litigation, which shows the number of lawsuits alleging serious or fatal internal bleeding has grown from 170 on January 14th to 260 as of March 5, 2013, an increase of over 50%.****

Those affected by internal bleeding after taking Pradaxa are encouraged to speak with a lawyer about their legal options. Since federal drug injury cases can be very specialized, DrugRisks only recommends lawyers who have already handled Pradaxa lawsuits.

Visit for more information on the research, Pradaxa side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

**Instutute for Safe Medication Practices, 1/9/13;

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
2. Approval of Safer Alternative to Pradaxa Delayed by FDA
3. Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
4. FDA: Dont Use Pradaxa Blood Thinner in Patients With Artificial Heart Valves
5. Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
6. Carey Danis & Lowe Issues an Update on the Pradaxa Multi-District Litigation No. 2385
7. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
8. DrugRisk Announces New Pradaxa Health Warning From Australia
9. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
10. Pradaxa Side Effect Problems Continue, as New Report Finds Pradaxa Bleeding More Likely to Result in Death, Bernstein Liebhard LLP Reports
11. Bernstein Liebhard LLP Launches Pradaxa Lawsuit Website Providing Information on Mounting Pradaxa Litigation, Side Effects
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, ... editors can give their videos a whole new perspective by using the title ... Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to choose ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 /PRNewswire/ ... Diabetes Tomorrow,s Leaders Scholarship is any indication, the future ... today online at by the Diabetes ... stand in the way of academic and community service ... scholarship program since 2012, and continues to advocate for ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology: